Fetuin‐A negatively correlates with liver and vascular fibrosis in nonalcoholic fatty liver disease subjects

Abstract

Serum fetuin-A level is associated with liver/vessel fibrosis-related markers in NAFLD patients. Circulating fetuin-A could be a useful serum biomarker for predicting liver and vascular fibrosis progression in NAFLD patients.